Global tumor protein p53/p63 interactome

References

• Helmbach H, Kern MA, Rossmann E, Renz K, Kissel C, Gschwendt B, et al. Drug resistance towards etoposide and cisplatin in human melanoma cells is associated with drug-dependent apoptosis deficiency. J Invest Dermatol 2002; 118:923 - 32; http://dx.doi.org/10.1046/j.1523-1747.2002.01786.x; PMID: 12060385
   PubMed Web of Science ®Google Scholar
• Zangen R, Ratovitski EA, Sidransky D. DeltaNp63α levels correlate with clinical tumor response to cisplatin. Cell Cycle 2005; 4:1313 - 5; http://dx.doi.org/10.4161/cc.4.10.2066; PMID: 16123597
   PubMed Web of Science ®Google Scholar
• Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 2007; 7:573 - 84; http://dx.doi.org/10.1038/nrc2167; PMID: 17625587
   PubMed Web of Science ®Google Scholar
• Flores ER, Tsai KY, Crowley D, Sengupta S, Yang A, McKeon F, et al. P63 and p73 are required for TP53-dependent apoptosis in response to DNA damage. Nature 2002; 416:560 - 4; http://dx.doi.org/10.1038/416560a; PMID: 11932750
   PubMed Web of Science ®Google Scholar
• Rocco JW, Leong CO, Kuperwasser N, DeYoung MP, Ellisen LW. p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. Cancer Cell 2006; 9:45 - 56; http://dx.doi.org/10.1016/j.ccr.2005.12.013; PMID: 16413471
   PubMed Web of Science ®Google Scholar
• Huang Y, Sen T, Nagpal J, Upadhyay S, Trink B, Ratovitski E, et al. ATM kinase is a master switch for the Δ Np63 α phosphorylation/degradation in human head and neck squamous cell carcinoma cells upon DNA damage. Cell Cycle 2008; 7:2846 - 55; http://dx.doi.org/10.4161/cc.7.18.6627; PMID: 18769144
   PubMed Web of Science ®Google Scholar
• Huang Y, Chuang AY, Romano RA, Liegeois NJ, Sinha S, Trink B, et al. Phospho-ΔNp63α/NF-Y protein complex transcriptionally regulates DDIT3 expression in squamous cell carcinoma cells upon cisplatin exposure. Cell Cycle 2010; 9:332 - 42; http://dx.doi.org/10.4161/cc.9.2.10432
   Web of Science ®Google Scholar
• Collavin L, Lunardi A, Del Sal G. p53-family proteins and their regulators: hubs and spokes in tumor suppression. Cell Death Differ 2010; 17:901 - 11; http://dx.doi.org/10.1038/cdd.2010.35; PMID: 20379196
   PubMed Web of Science ®Google Scholar
• Tozluoğlu M, Karaca E, Haliloglu T, Nussinov R. Cataloging and organizing p73 interactions in cell cycle arrest and apoptosis. Nucleic Acids Res 2008; 36:5033 - 49; http://dx.doi.org/10.1093/nar/gkn481; PMID: 18660513
   PubMed Web of Science ®Google Scholar
• Ratovitski EA, Patturajan M, Hibi K, Trink B, Yamaguchi K, Sidransky D. p53 associates with and targets Δ Np63 into a protein degradation pathway. Proc Natl Acad Sci USA 2001; 98:1817 - 22; http://dx.doi.org/10.1073/pnas.98.4.1817; PMID: 11172034
   PubMed Web of Science ®Google Scholar
• Zeng SX, Dai MS, Keller DM, Lu H. SSRP1 functions as a co-activator of the transcriptional activator p63. EMBO J 2002; 21:5487 - 97; http://dx.doi.org/10.1093/emboj/cdf540; PMID: 12374749
   PubMed Web of Science ®Google Scholar
• Patturajan M, Nomoto S, Sommer M, Fomenkov A, Hibi K, Zangen R, et al. DeltaNp63 induces β-catenin nuclear accumulation and signaling. Cancer Cell 2002; 1:369 - 79; http://dx.doi.org/10.1016/S1535-6108(02)00057-0; PMID: 12086851
   PubMed Web of Science ®Google Scholar
• Fomenkov A, Huang YP, Topaloglu O, Brechman A, Osada M, Fomenkova T, et al. P63 α mutations lead to aberrant splicing of keratinocyte growth factor receptor in the Hay-Wells syndrome. J Biol Chem 2003; 278:23906 - 14; http://dx.doi.org/10.1074/jbc.M300746200; PMID: 12692135
   PubMed Web of Science ®Google Scholar
• Huang YP, Wu G, Guo Z, Osada M, Fomenkov T, Park HL, et al. Altered sumoylation of p63α contributes to the split-hand/foot malformation phenotype. Cell Cycle 2004; 3:1587 - 96; http://dx.doi.org/10.4161/cc.3.12.1290; PMID: 15539951
   PubMed Web of Science ®Google Scholar
• MacPartlin M, Zeng S, Lee H, Stauffer D, Jin Y, Thayer M, et al. p300 regulates p63 transcriptional activity. J Biol Chem 2005; 280:30604 - 10; http://dx.doi.org/10.1074/jbc.M503352200; PMID: 15965232
   PubMed Web of Science ®Google Scholar
• Rossi M, Aqeilan RI, Neale M, Candi E, Salomoni P, Knight RA, et al. The E3 ubiquitin ligase Itch controls the protein stability of p63. Proc Natl Acad Sci USA 2006; 103:12753 - 8; http://dx.doi.org/10.1073/pnas.0603449103; PMID: 16908849
   PubMed Web of Science ®Google Scholar
• Wang N, Guo L, Rueda BR, Tilly JL. Cables1 protects p63 from proteasomal degradation to ensure deletion of cells after genotoxic stress. EMBO Rep 2010; 11:633 - 9; http://dx.doi.org/10.1038/embor.2010.82; PMID: 20559324
   PubMed Web of Science ®Google Scholar
• Chatterjee A, Chang X, Sen T, Ravi R, Bedi A, Sidransky D. Regulation of p53 family member isoform DeltaNp63alpha by the nuclear factor-kappaB targeting kinase IkappaB kinase beta. Cancer Res 2010; 70:1419 - 29; http://dx.doi.org/10.1158/0008-5472.CAN-09-2613; PMID: 20145131
   PubMed Web of Science ®Google Scholar
• Amoresano A, Di Costanzo A, Leo G, Di Cunto F, La Mantia G, Guerrini L, et al. Identification of DeltaNp63α protein interactions by mass spectrometry. J Proteome Res 2010; 9:2042 - 8; http://dx.doi.org/10.1021/pr9011156; PMID: 20085233
   PubMed Web of Science ®Google Scholar
• Zhu H, Bilgin M, Bangham R, Hall D, Casamayor A, Bertone P, et al. Global analysis of protein activities using proteome chips. Science 2001; 293:2101 - 5; http://dx.doi.org/10.1126/science.1062191; PMID: 11474067
   PubMed Web of Science ®Google Scholar
• Bai Y, Markham K, Chen F, Weerasekera R, Watts J, Horne P, et al. The in vivo brain interactome of the amyloid precursor protein. Mol Cell Proteomics 2008; 7:15 - 34; http://dx.doi.org/10.1074/mcp.M700077-MCP200; PMID: 17934213
   PubMed Web of Science ®Google Scholar
• Schweitzer B, Predki P, Snyder M. Microarrays to characterize protein interactions on a whole-proteome scale. Proteomics 2003; 3:2190 - 9; http://dx.doi.org/10.1002/pmic.200300610; PMID: 14595818
   PubMed Web of Science ®Google Scholar
• Schnack C, Hengerer B, Gillardon F. Identification of novel substrates for Cdk5 and new targets for Cdk5 inhibitors using high-density protein microarrays. Proteomics 2008; 8:1980 - 6; http://dx.doi.org/10.1002/pmic.200701063; PMID: 18491313
   PubMed Web of Science ®Google Scholar
• O’Connell DJ, Bauer MC, O’Brien J, Johnson WM, Divizio CA, O’Kane SL, et al. Integrated protein array screening and high throughput validation of 70 novel neural calmodulin-binding proteins. Mol Cell Proteomics 2010; 9:1118 - 32; http://dx.doi.org/10.1074/mcp.M900324-MCP200; PMID: 20068228
   PubMed Web of Science ®Google Scholar
• McFarland MA, Ellis CE, Markey SP, Nussbaum RL. Proteomics analysis identifies phosphorylation-dependent α-synuclein protein interactions. Mol Cell Proteomics 2008; 7:2123 - 37; http://dx.doi.org/10.1074/mcp.M800116-MCP200; PMID: 18614564
   PubMed Web of Science ®Google Scholar
• Pflieger D, Jünger MA, Müller M, Rinner O, Lee H, Gehrig PM, et al. Quantitative proteomic analysis of protein complexes: concurrent identification of interactors and their state of phosphorylation. Mol Cell Proteomics 2008; 7:326 - 46; http://dx.doi.org/10.1074/mcp.M700282-MCP200; PMID: 17956857
   PubMed Web of Science ®Google Scholar
• Bousquet-Dubouch MP, Baudelet E, Guérin F, Matondo M, Uttenweiler-Joseph S, Burlet-Schiltz O, et al. Affinity purification strategy to capture human endogenous proteasome complexes diversity and to identify proteasome-interacting proteins. Mol Cell Proteomics 2009; 8:1150 - 64; http://dx.doi.org/10.1074/mcp.M800193-MCP200; PMID: 19193609
   PubMed Web of Science ®Google Scholar
• Chen LC, Chung IC, Hsueh C, Tsang NM, Chi LM, Liang Y, et al. The antiapoptotic protein, FLIP, is regulated by heterogeneous nuclear ribonucleoprotein K and correlates with poor overall survival of nasopharyngeal carcinoma patients. Cell Death Differ 2010; 17:1463 - 73; http://dx.doi.org/10.1038/cdd.2010.24; PMID: 20224598
   PubMed Web of Science ®Google Scholar
• Kaake RM, Wang X, Huang L. Profiling of protein interaction networks of protein complexes using affinity purification and quantitative mass spectrometry. Mol Cell Proteomics 2010; 9:1650 - 65; http://dx.doi.org/10.1074/mcp.R110.000265; PMID: 20445003
   PubMed Web of Science ®Google Scholar
• Moore MJ, Wang Q, Kennedy CJ, Silver PA. An alternative splicing network links cell-cycle control to apoptosis. Cell 2010; 142:625 - 36; http://dx.doi.org/10.1016/j.cell.2010.07.019; PMID: 20705336
   PubMed Web of Science ®Google Scholar
• Jang SW, Yang SJ, Ehlén A, Dong S, Khoury H, Chen J, et al. Serine/arginine protein-specific kinase 2 promotes leukemia cell proliferation by phosphorylating acinus and regulating cyclin A1. Cancer Res 2008; 68:4559 - 70; http://dx.doi.org/10.1158/0008-5472.CAN-08-0021; PMID: 18559500
   PubMed Web of Science ®Google Scholar
• Zhong XY, Ding JH, Adams JA, Ghosh G, Fu XD. Regulation of SR protein phosphorylation and alternative splicing by modulating kinetic interactions of SRPK1 with molecular chaperones. Genes Dev 2009; 23:482 - 95; http://dx.doi.org/10.1101/gad.1752109; PMID: 19240134
   PubMed Web of Science ®Google Scholar
• Schwerk C, Prasad J, Degenhardt K, Erdjument-Bromage H, White E, Tempst P, et al. ASAP, a novel protein complex involved in RNA processing and apoptosis. Mol Cell Biol 2003; 23:2981 - 90; http://dx.doi.org/10.1128/MCB.23.8.2981-2990.2003; PMID: 12665594
   PubMed Web of Science ®Google Scholar
• Joselin AP, Schulze-Osthoff K, Schwerk C. Loss of Acinus inhibits oligonucleosomal DNA fragmentation but not chromatin condensation during apoptosis. J Biol Chem 2006; 281:12475 - 84; http://dx.doi.org/10.1074/jbc.M509859200; PMID: 16537548
   PubMed Web of Science ®Google Scholar
• Jiang ZH, Zhang WJ, Rao Y, Wu JY. Regulation of Ich-1 pre-mRNA alternative splicing and apoptosis by mammalian splicing factors. Proc Natl Acad Sci USA 1998; 95:9155 - 60; http://dx.doi.org/10.1073/pnas.95.16.9155; PMID: 9689050
   PubMed Web of Science ®Google Scholar
• Fushimi K, Ray P, Kar A, Wang L, Sutherland LC, Wu JY. Up-regulation of the proapoptotic caspase 2 splicing isoform by a candidate tumor suppressor, RBM5. Proc Natl Acad Sci USA 2008; 105:15708 - 13; http://dx.doi.org/10.1073/pnas.0805569105; PMID: 18840686
   PubMed Web of Science ®Google Scholar
• Huang YP, Kim Y, Li Z, Fomenkov T, Fomenkov A, Ratovitski EA. AEC-associated p63 mutations lead to alternative splicing/protein stabilization of p63 and modulation of Notch signaling. Cell Cycle 2005; 4:1440 - 7; http://dx.doi.org/10.4161/cc.4.10.2086; PMID: 16177572
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhang L, Jones KA. SKIP counteracts p53-mediated apoptosis via selective regulation of p21Cip1 mRNA splicing. Genes Dev 2011; 25:701 - 16; http://dx.doi.org/10.1101/gad.2002611; PMID: 21460037
   PubMed Web of Science ®Google Scholar
• Edmond V, Brambilla C, Brambilla E, Gazzeri S, Eymin B. SRSF2 is required for sodium butyrate-mediated p21(WAF1) induction and premature senescence in human lung carcinoma cell lines. Cell Cycle 2011; 10:1968 - 77; http://dx.doi.org/10.4161/cc.10.12.15825; PMID: 21555914
   PubMed Web of Science ®Google Scholar
• Albers M, Kranz H, Kober I, Kaiser C, Klink M, Suckow J, et al. Automated yeast two-hybrid screening for nuclear receptor-interacting proteins. Mol Cell Proteomics 2005; 4:205 - 13; http://dx.doi.org/10.1074/mcp.M400169-MCP200; PMID: 15604093
   PubMed Web of Science ®Google Scholar
• Gingras AC, Caballero M, Zarske M, Sanchez A, Hazbun TR, Fields S, et al. A novel, evolutionarily conserved protein phosphatase complex involved in cisplatin sensitivity. Mol Cell Proteomics 2005; 4:1725 - 40; http://dx.doi.org/10.1074/mcp.M500231-MCP200; PMID: 16085932
   PubMed Web of Science ®Google Scholar
• Stewart JJ, White JT, Yan X, Collins S, Drescher CW, Urban ND, et al. Proteins associated with Cisplatin resistance in ovarian cancer cells identified by quantitative proteomic technology and integrated with mRNA expression levels. Mol Cell Proteomics 2006; 5:433 - 43; http://dx.doi.org/10.1074/mcp.M500140-MCP200; PMID: 16319398
   PubMed Web of Science ®Google Scholar
• Tu LC, Yan X, Hood L, Lin B. Proteomics analysis of the interactome of N-myc downstream regulated gene 1 and its interactions with the androgen response program in prostate cancer cells. Mol Cell Proteomics 2007; 6:575 - 88; http://dx.doi.org/10.1074/mcp.M600249-MCP200; PMID: 17220478
   PubMed Web of Science ®Google Scholar
• Chavez JD, Hoopmann MR, Weisbrod CR, Takara K, Bruce JE. Quantitative proteomic and interaction network analysis of cisplatin resistance in HeLa cells. PLoS ONE 2011; 6:e19892; http://dx.doi.org/10.1371/journal.pone.0019892; PMID: 21637840
   PubMed Web of Science ®Google Scholar
• Gatti L, Zunino F. Overview of tumor cell chemoresistance mechanisms. Methods Mol Med 2005; 111:127 - 48; PMID: 15911977
   PubMedGoogle Scholar
• Righetti PG, Castagna A, Antonioli P, Cecconi D, Campostrini N, Righetti SC. Proteomic approaches for studying chemoresistance in cancer. Expert Rev Proteomics 2005; 2:215 - 28; http://dx.doi.org/10.1586/14789450.2.2.215; PMID: 15892566
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, et al. Molecular mechanisms of cisplatin resistance. Oncogene 2012; 31:1869 - 83; http://dx.doi.org/10.1038/onc.2011.384; PMID: 21892204
   PubMed Web of Science ®Google Scholar
• Sen T, Sen N, Brait M, Begum S, Chatterjee A, Hoque MO, et al. ΔNp63α confers tumor cell resistance to cisplatin treatment through the AKT transcriptional regulation. Cancer Res 2011; 71:1167 - 76; http://dx.doi.org/10.1158/0008-5472.CAN-10-1481; PMID: 21266360
   PubMed Web of Science ®Google Scholar
• Chandler DS, Singh RK, Caldwell LC, Bitler JL, Lozano G. Genotoxic stress induces coordinately regulated alternative splicing of the p53 modulators MDM2 and MDM4. Cancer Res 2006; 66:9502 - 8; http://dx.doi.org/10.1158/0008-5472.CAN-05-4271; PMID: 17018606
   PubMed Web of Science ®Google Scholar
• Hayes GM, Carrigan PE, Beck AM, Miller LJ. Targeting the RNA splicing machinery as a novel treatment strategy for pancreatic carcinoma. Cancer Res 2006; 66:3819 - 27; http://dx.doi.org/10.1158/0008-5472.CAN-05-4065; PMID: 16585209
   PubMed Web of Science ®Google Scholar
• Ezponda T, Pajares MJ, Agorreta J, Echeveste JI, López-Picazo JM, Torre W, et al. The oncoprotein SF2/ASF promotes non-small cell lung cancer survival by enhancing survivin expression. Clin Cancer Res 2010; 16:4113 - 25; http://dx.doi.org/10.1158/1078-0432.CCR-10-0076; PMID: 20682707
   PubMed Web of Science ®Google Scholar
• Edmond V, Moysan E, Khochbin S, Matthias P, Brambilla C, Brambilla E, et al. Acetylation and phosphorylation of SRSF2 control cell fate decision in response to cisplatin. EMBO J 2011; 30:510 - 23; http://dx.doi.org/10.1038/emboj.2010.333; PMID: 21157427
   PubMed Web of Science ®Google Scholar
• Shkreta L, Michelle L, Toutant J, Tremblay ML, Chabot B. The DNA damage response pathway regulates the alternative splicing of the apoptotic mediator Bcl-x. J Biol Chem 2011; 286:331 - 40; http://dx.doi.org/10.1074/jbc.M110.162644; PMID: 20980256
   PubMed Web of Science ®Google Scholar
• Huang YP, Chuang A, Hao H, Talbot CC, Trink B, Sidransky D, et al. Phospho-ΔNp63α is a key regulator of cisplatin-induced microRNAome in head and neck squamous cell carcinoma cells. Cell Death Differ 2011; 18:1220 - 30; http://dx.doi.org/10.1038/cdd.2010.188; PMID: 21274007
   PubMed Web of Science ®Google Scholar
• Blaustein M, Pelisch F, Tanos T, Muñoz MJ, Wengier D, Quadrana L, et al. Concerted regulation of nuclear and cytoplasmic activities of SR proteins by AKT. Nat Struct Mol Biol 2005; 12:1037 - 44; http://dx.doi.org/10.1038/nsmb1020; PMID: 16299516
   PubMed Web of Science ®Google Scholar
• Hu Y, Yao J, Liu Z, Liu X, Fu H, Ye K. Akt phosphorylates acinus and inhibits its proteolytic cleavage, preventing chromatin condensation. EMBO J 2005; 24:3543 - 54; http://dx.doi.org/10.1038/sj.emboj.7600823; PMID: 16177823
   PubMed Web of Science ®Google Scholar
• Singh KK, Erkelenz S, Rattay S, Dehof AK, Hildebrandt A, Schulze-Osthoff K, et al. Human SAP18 mediates assembly of a splicing regulatory multiprotein complex via its ubiquitin-like fold. RNA 2010; 16:2442 - 54; http://dx.doi.org/10.1261/rna.2304410; PMID: 20966198
   PubMed Web of Science ®Google Scholar
• Mazan-Mamczarz K, Galbán S, López de Silanes I, Martindale JL, Atasoy U, Keene JD, et al. RNA-binding protein HuR enhances p53 translation in response to ultraviolet light irradiation. Proc Natl Acad Sci USA 2003; 100:8354 - 9; http://dx.doi.org/10.1073/pnas.1432104100; PMID: 12821781
   PubMed Web of Science ®Google Scholar
• Shu L, Yan W, Chen X. RNPC1, an RNA-binding protein and a target of the p53 family, is required for maintaining the stability of the basal and stress-induced p21 transcript. Genes Dev 2006; 20:2961 - 72; http://dx.doi.org/10.1101/gad.1463306; PMID: 17050675
   PubMed Web of Science ®Google Scholar
• Cho SJ, Zhang J, Chen X. RNPC1 modulates the RNA-binding activity of, and cooperates with, HuR to regulate p21 mRNA stability. Nucleic Acids Res 2010; 38:2256 - 67; http://dx.doi.org/10.1093/nar/gkp1229; PMID: 20064878
   PubMed Web of Science ®Google Scholar
• Zhang J, Jun Cho S, Chen X. RNPC1, an RNA-binding protein and a target of the p53 family, regulates p63 expression through mRNA stability. Proc Natl Acad Sci USA 2010; 107:9614 - 9; http://dx.doi.org/10.1073/pnas.0912594107; PMID: 20457941
   PubMed Web of Science ®Google Scholar
• Kuzmichev A, Zhang Y, Erdjument-Bromage H, Tempst P, Reinberg D. Role of the Sin3-histone deacetylase complex in growth regulation by the candidate tumor suppressor p33(ING1). Mol Cell Biol 2002; 22:835 - 48; http://dx.doi.org/10.1128/MCB.22.3.835-848.2002; PMID: 11784859
   PubMed Web of Science ®Google Scholar
• Sykes SM, Mellert HS, Holbert MA, Li K, Marmorstein R, Lane WS, et al. Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol Cell 2006; 24:841 - 51; http://dx.doi.org/10.1016/j.molcel.2006.11.026; PMID: 17189187
   PubMed Web of Science ®Google Scholar
• Tang Y, Luo J, Zhang W, Gu W. Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol Cell 2006; 24:827 - 39; http://dx.doi.org/10.1016/j.molcel.2006.11.021; PMID: 17189186
   PubMed Web of Science ®Google Scholar
• Miyamoto N, Izumi H, Noguchi T, Nakajima Y, Ohmiya Y, Shiota M, et al. Tip60 is regulated by circadian transcription factor clock and is involved in cisplatin resistance. J Biol Chem 2008; 283:18218 - 26; http://dx.doi.org/10.1074/jbc.M802332200; PMID: 18458078
   PubMed Web of Science ®Google Scholar
• Maiuri MC, Galluzzi L, Morselli E, Kepp O, Malik SA, Kroemer G. Autophagy regulation by p53. Curr Opin Cell Biol 2010; 22:181 - 5; http://dx.doi.org/10.1016/j.ceb.2009.12.001; PMID: 20044243
   PubMed Web of Science ®Google Scholar
• Morselli E, Shen S, Ruckenstuhl C, Bauer MA, Mariño G, Galluzzi L, et al. p53 inhibits autophagy by interacting with the human ortholog of yeast Atg17, RB1CC1/FIP200. Cell Cycle 2011; 10:2763 - 9; http://dx.doi.org/10.4161/cc.10.16.16868; PMID: 21775823
   PubMed Web of Science ®Google Scholar
• Sen T, Chang X, Sidransky D, Chatterjee A. Regulation of ΔNp63α by NFκΒ. Cell Cycle 2010; 9:4841 - 7; http://dx.doi.org/10.4161/cc.9.24.14093; PMID: 21088498
   PubMed Web of Science ®Google Scholar
• Bagnoli M, De Cecco L, Granata A, Nicoletti R, Marchesi E, Alberti P, et al. Identification of a chrXq27.3 microRNA cluster associated with early relapse in advanced stage ovarian cancer patients. Oncotarget 2011; 2:1265 - 78; PMID: 22246208
   PubMed Web of Science ®Google Scholar
• Neilsen PM, Noll JE, Suetani RJ, Schulz RB, Al-Ejeh F, Evdokiou A, et al. Mutant p53 uses p63 as a molecular chaperone to alter gene expression and induce a pro-invasive secretome. Oncotarget 2011; 2:1203 - 17; PMID: 22203497
   PubMed Web of Science ®Google Scholar
• Ory B, Ellisen LW. A microRNA-dependent circuit controlling p63/p73 homeostasis: p53 family cross-talk meets therapeutic opportunity. Oncotarget 2011; 2:259 - 64; PMID: 21436470
   PubMed Web of Science ®Google Scholar
• Nijwening JH, Kuiken HJ, Beijersbergen RL. Screening for modulators of cisplatin sensitivity: unbiased screens reveal common themes. Cell Cycle 2011; 10:380 - 6; http://dx.doi.org/10.4161/cc.10.3.14642; PMID: 21239890
   PubMed Web of Science ®Google Scholar
• Jeong JS, Jiang L, Albino E, Marrero J, Rho HS, Hu J, et al. Rapid identification of monospecific monoclonal antibodies using a human proteome microarray. Mol Cell Proteomics 2012; In press http://dx.doi.org/10.1074/mcp.O111.016253; PMID: 22307071
   PubMed Web of Science ®Google Scholar